These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16158351)

  • 1. Nitric oxide-releasing NSAIDs: GI-safe antithrombotics.
    Wallace JL; Del Soldato P; Cirino G; Muscará MN
    IDrugs; 1999 Apr; 2(4):321-6. PubMed ID: 16158351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a new generation of antithrombotics?
    Wallace JL; Del Soldato P; Cirino G
    Expert Opin Investig Drugs; 1997 May; 6(5):533-8. PubMed ID: 15989618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs.
    Nemmani KV; Mali SV; Borhade N; Pathan AR; Karwa M; Pamidiboina V; Senthilkumar SP; Gund M; Jain AK; Mangu NK; Dubash NP; Desai DC; Sharma S; Satyam A
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5297-301. PubMed ID: 19683923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCX-4016 NicOx SA.
    Huizinga TW
    IDrugs; 1998 Jun; 1(2):228-31. PubMed ID: 18465536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
    Gresele P; Momi S
    Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building a better aspirin: gaseous solutions to a century-old problem.
    Wallace JL
    Br J Pharmacol; 2007 Oct; 152(4):421-8. PubMed ID: 17641669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat.
    Carini M; Aldini G; Orioli M; Piccoli A; Rossoni G; Maffei Facino R
    Life Sci; 2004 May; 74(26):3291-305. PubMed ID: 15094329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.
    Wallace JL; Vong L
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1151-6. PubMed ID: 18951293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3014-8. PubMed ID: 19419861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Lanas A; Scheiman J
    Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen sulfide-releasing anti-inflammatory drugs.
    Wallace JL
    Trends Pharmacol Sci; 2007 Oct; 28(10):501-5. PubMed ID: 17884186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis.
    Wallace JL; Viappiani S; Bolla M
    Trends Pharmacol Sci; 2009 Mar; 30(3):112-7. PubMed ID: 19230986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
    Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
    Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for drug-drug interactions in patients taking analgesics for mild-to-moderate pain and low-dose aspirin for cardioprotection.
    Gaziano JM; Gibson CM
    Am J Cardiol; 2006 May; 97(9A):23-9. PubMed ID: 16675319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines.
    Rosetti M; Tesei A; Ulivi P; Fabbri F; Vannini I; Brigliadori G; Amadori D; Bolla M; Zoli W
    Apoptosis; 2006 Aug; 11(8):1321-30. PubMed ID: 16699954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.